Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease

NCT02883426 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

NIH

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV)
BIOLOGICAL: H3N2v inactivated subvirion influenza vaccine
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)